Press releaseBusiness Wire
Novanta
NOVT · NASDAQ
$135.59+$4.07 (+3.09%)TodayMarket closed ·
Prev close $131.52
About NOVT
- Employees
- 3,000
- Headquarters
- Bedford, Massachusetts
- Listed
- Mar 24, 1999
- Sector
- Information Technology
- Industry
- Electronic Equipment, Instruments & Components
- Website
- novanta.com
NOVT key statistics
- Market cap
- 4.97B
- Price-earnings ratio
- 83.77
- Dividend yield
- —
- Average volume
- 431.19K
- Volume
- 253.82K
- Open price
- $130.08
- High today
- $139.50
- Low today
- $128.61
- 52 Week high
- $176.38
- 52 Week low
- $98.27
Novanta (NOVT) at a glance
Novanta (NOVT) last traded at $135.59, with a market cap of 4.97B and a price-to-earnings ratio of 83.77.
Today the stock has traded between $128.61 and $139.50. The current price is 5.4% above the day's low and 2.8% below its high.
Volume so far is 253.82K shares, below the average of 431.19K shares a day.
Over the past year Novanta has ranged from $98.27 to $176.38, and now sits 48% of the way up that range.
Novanta met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.89 per share against an estimate of $0.8466.
The average analyst price target is $198.39, 46.3% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
100%of 1 analyst rating say Buy
- Buy100.0%
- Hold0.0%
- Sell0.0%
Price target · 4 analystsAvg $198.39
- Low
- $195.94
- Now
- $135.59
- High
- $204.75
NOVT earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 3.9% on average.
- Q3 FY24: reported $0.85 per share against an estimate of $0.8704
- Q4 FY24: reported $0.76 per share against an estimate of $0.7276
- Q1 FY25: reported $0.74 per share against an estimate of $0.6868
- Q2 FY25: reported $0.76 per share against an estimate of $0.748
- Q3 FY25: reported $0.87 per share against an estimate of $0.833
- Q4 FY25: reported $0.91 per share against an estimate of $0.8976
- Q1 FY26: reported $0.81 per share against an estimate of $0.7922
- Q2 FY26: reported $0.89 per share against an estimate of $0.8466
NOVT news
- Press releaseBusiness Wire
Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call
- Press releaseBusiness Wire
Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026
- Press releaseBusiness Wire
Novanta Announces Financial Results for the Second Quarter 2026
- Press releaseBusiness Wire
Novanta Completes Acquisition of Riverpoint Medical
- Press releaseBusiness Wire
Novanta Inc. Announces Schedule of Second Quarter 2026 Earnings Release and Conference Call
- Press releaseBusiness Wire
Novanta to Present at the CJS Securities 26th Annual New Ideas Summer Conference on Thursday, July 9, 2026
- Press releaseBusiness Wire
Novanta Inc. Announces $300 Million Private Placement
Similar companies
Companies in the same industry as Novanta
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- FRTTFort Technology$0.7121+32.63%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.